Reviewed by Pieter Cohen, MD, Contributor Peptides are getting a lot of attention on social media, purporting to support everything from muscle growth and skin health to improved energy, cognitive function, and sleep quality
Emerging data on tirzepatide transfer into human milk (study under review)
Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Not Controlled With Diet and Exercise Alone (SURPASS) studies have shown that tirzepatide reduced HbA1c and fasting glucose levels more than the titrated insulin degludec, insulin glargine or 1 mg once a week semaglutide independently of the baseline levels of HbA1c
CagriSema remains under FDA review and is not approved
The study looked at the change from baseline in LFC as assessed by MRI-proton density fat fraction (MRI-PDFF) at week 52
Although they are marketed as next-generation biohacks and research chemicals, many peptides are not approved for human use and lack basic clinical testing